Katz, A <br/><br/>
Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 therapy.  [electronic resource] 

 -  Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy  Feb 1993 
 - 98-109 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1067-5582 
<br/><br/><label>Standard No.: </label>10.1097/00002371-199302000-00004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Histocompatibility Antigens Class I--analysis<br/>Immunotherapy<br/>Interleukin-6--administration & dosage<br/>Lung Neoplasms--secondary<br/>Melanoma, Experimental--immunology<br/>Mice<br/>Mice, Inbred C57BL<br/>Receptors, Immunologic--analysis<br/>Receptors, Interleukin-6<br/>Recombinant Proteins--administration & dosage<br/>Tumor Cells, Cultured